In a Roll-Up, the Onboarding Playbook Is the Asset — Not the Individual Deal

The shape of private equity healthcare activity says something useful about what platforms actually need operationally. The Private Equity Stakeholder Project tracked 1,029 private equity healthcare transactions in 2025 — and of those, 664 were add-on acquisitions, against 151 leveraged buyouts and 214 growth investments (Private Equity Stakeholder Project, compiled from PitchBook and LevinPro HC data). Add-ons outnumber new platform formations by better than four to one.

Add-on-heavy dealmaking makes integration a repeated process, not a project

A platform that will acquire a dozen practices over a hold period doesn't need a good integration once. It needs the same integration twelve times, executed by people who won't all be the same people, at a consistency level that doesn't decay as the platform gets busier. That's a fundamentally different operational requirement than doing one careful conversion — and it's the requirement most platforms underestimate, because the first one or two acquisitions usually go fine on attention and effort alone.

Every acquired practice arrives with its own billing maturity

One target has a tenured biller who knows every payer rep by name and keeps a denial log in a spreadsheet nobody else can read. The next outsourced billing years ago and has no institutional knowledge left in-house at all. A third has been coding conservatively for a decade and is leaving money on the table in a way that looks like clean performance until someone audits it. Standardizing all three onto platform workflows without a cash-flow dip during transition is the actual work — and "we'll figure out each one as it comes" is how a platform ends up with twelve billing operations wearing one logo.

Credentialing timing is where deal value quietly slips

A newly acquired provider who isn't yet enrolled under the platform's payer contracts can't bill at the platform's negotiated rates. Every week of lag between close and enrollment is a week the acquired practice is producing revenue at its old economics rather than the ones the deal was underwritten on. That gap doesn't show up as a failure — the practice is still billing, claims are still paying — which is exactly why it goes unnoticed until someone reconciles realized synergy against the model.

Portfolio reporting has to be comparable, not just present

Boards and diligence on the next add-on both need RCM metrics that mean the same thing across every practice in the portfolio. If days-in-AR is calculated one way at three practices and another way at the rest, the portfolio view isn't a view — it's an average of incompatible numbers. Getting definitions standardized at onboarding, rather than reconciling them at reporting time, is the difference between a metric leadership can act on and a number that starts an argument.

See how we support MSOs and PE-backed groups running repeatable acquisition onboarding across a growing platform.

Industry statistics cited above are drawn from the Private Equity Stakeholder Project's 2025 healthcare deals report as noted and are not medbpo360's own client data.